查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
虛擬實境暴露療法市場：2023年至2028年預測
市場調查報告書
商品編碼
1410178

虛擬實境暴露療法市場：2023年至2028年預測

Virtual Reality Exposure Therapy Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

虛擬實境暴露療法市場預計在預測期內複合年成長率為 38.53%。

虛擬實境暴露療法（VRET）市場是心理健康療法中改變遊戲規則的部分，它使用尖端的虛擬實境（VR）技術來治療各種焦慮症和恐懼症。 VRET 提供了一個安全、受控的環境，讓患者可以透過逐漸、反覆接觸引起焦慮的刺激來控制焦慮。 VRET 透過讓患者沉浸在虛擬環境中來模擬現實生活環境，使治療師能夠以受控和監督的方式指導客戶完成治療課程。這種身臨其境型和參與式的方法已被證明有助於治療創傷後壓力症候群、社交焦慮和特定恐懼症疾病。隨著心理健康專業人士和患者接受這種新穎且有前景的治療方法，虛擬實境暴露療法市場可能會顯著成長。

虛擬實境技術的進步正在推動虛擬實境暴露療法市場的成長。

虛擬實境 (VR) 技術的進步極大地改善了虛擬實境暴露療法 (VRET) 體驗，並推動了心理健康治療的創新。 VR 技術的發展可以提供高度沉浸式和真實的體驗，給患者一種臨場感和參與感。透過解析度、圖形和運動追蹤功能的改進，可以實現更真實和動態的虛擬世界。這些進步使治療師能夠創建更接近現實生活情況的客製化設置，從而使他們能夠提供個人化的暴露治療。此外，使用者友好且易於使用的 VR 設備的開發擴大了可以使用 VRET 的患者範圍，使其在治療環境中更容易使用。隨著 VR 技術的進步，它有可能透過提供更有效、更有前景的治療方法來改變精神健康保健領域。

在虛擬實境暴露療法市場中，人們對非侵入性治療方法的認知和採用不斷增加。

對非侵入性治療方法的日益接受和理解正在顯著推動虛擬實境暴露療法（VRET）市場的成長。非侵入性治療在尋求替代治療的人中越來越受歡迎，因為它們不需要侵入性手術或藥物，並且可以提供優異的效果。 VRET順應了這一趨勢，透過身臨其境型虛擬體驗提供了一種非侵入性的方法來治療焦慮症和恐懼症。隨著心理健康專業人員和患者越來越意識到非侵入性治療的好處，對 VRET 的需求正在增加。其安全性、個體化方法以及將有害副作用降至最低的能力使這種治療成為現代精神健康保健的流行選擇。

個體化和標靶化的治療方法將推動虛擬實境暴露療法市場規模。

個人化和量身定做的治療技術正在推動虛擬實境暴露療法（VRET）市場的發展。 VRET 讓治療師根據特定患者的恐懼和焦慮來設計客製化的虛擬情境。 VRET 透過個人化虛擬體驗提供高度個人化的治療方法，確保患者在受控和支持的環境中面對觸發因素。這種程度的客製化使治療師能夠解決每個患者的個人需求和障礙，從而獲得更有效和成功的結果。由於VRET可以專注於特定的恐懼，因此它已成為提高治療效果、更準確地治療許多焦慮症和恐懼症以及提高患者滿意度的有用工具。

北美是虛擬實境暴露療法市場的領導者。

北美是虛擬實境暴露療法（VRET）市場的領導者。該地區處於主導地位的原因有很多，包括現代化的醫療基礎設施、心理健康問題的高發生率以及虛擬實境技術在治療環境中的早期使用。幾家知名公司和新興企業正在北美提供 VRET 解決方案，支援創新並推動虛擬實境暴露治療市場的成長。此外，該地區的支持性法律規範以及人們對 VRET 在治療焦慮和恐懼症方面的益處的了解不斷增加，正在推動市場佔有率。隨著 VRET 在世界各地的普及，北美仍然處於其採用和發展的最前沿。

虛擬實境暴露療法在虛擬實境暴露療法市場的臨床環境中的整合。

虛擬實境暴露療法（VRET）的臨床整合徹底改變了心理健康療法。 VRET 被治療師無縫整合，作為補充標準治療方法的寶貴工具。在受控情況下，使用身臨其境型虛擬世界可以系統地對引起焦慮的刺激脫敏。 VRET 使治療師能夠更快地實施暴露治療，同時準確監測患者的進展。透過模擬現實生活中的情況，患者可以在安全的環境中面對焦慮，從而減少迴避行為並改善應對策略。此外，VRET可用於治療各種焦慮症和恐懼症，並提高其在治療環境中的適應性和有效性。隨著越來越多的心理健康專業人士接受 VRET，VRET 對心理健康護理的革命性影響將繼續成長，從而為患者帶來更大的治療益處。

主要進展：

2022年5月，虛擬實境先驅OxfordVR宣布完成1,250萬美元的A輪資金籌措，這是英國和歐洲VR治療領域最大的資金籌措。 2022 年 12 月，兩家虛擬實境心理和行為健康公司 BehaVR 和 OxfordVR 宣布獲得 1,300 萬美元的 B 輪融資，由 Optum Ventures 和 Oxford Science Enterprises主導，Confluence Health、Accenture Ventures、Chrysalis Ventures 和Thornton Capital 跟投。本輪融資後，我們此時宣布合併。

公司產品

  • 虛擬實境分析平台： CognitiveVR 可能會提供一個完整的分析平台，讓心理健康醫生和研究人員收集和分析 VRET 會話的資料。在暴露治療期間，該平台可以監測患者的反應、行為和進展。
  • 身臨其境型虛擬環境： OxfordVR 計畫提供一個真實的虛擬環境庫，反映現實生活場景，幫助患者面對並逐步克服他們特定的恐懼症和焦慮症。
  • 虛擬實境硬體：我們提供一系列虛擬實境技術，例如耳機和運動追蹤控制器，為患者提供高度逼真且引人入勝的 VRET 體驗。
  • LimbixVR應用程式： Limbix有望為輻射暴露治療提供使用者友好且有吸引力的虛擬實境軟體。該應用程式提供了一個沉浸式且可配置的場景庫，這些場景反映了現實生活中的情況，並有可能允許治療師為患者建立客製化的暴露課程。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 資訊來源
  • 研究設計

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 業內競爭對手之間的對抗關係
  • 產業價值鏈分析

第5章虛擬實境暴露治療市場：按組成部分

  • 介紹
  • 硬體
  • 軟體

第6章虛擬實境暴露治療市場：依應用分類

  • 介紹
  • 焦慮症
  • 創傷後壓力症候群（PTSD）
  • 恐懼症和特定的恐懼
  • 恐慌症
  • 強迫性精神官能症(OCD)
  • 其他

第7章虛擬實境暴露治療市場：依類型

  • 介紹
  • 監控和健康追蹤
  • 疾病管理
  • 遠距醫療和遠端醫療
  • 藥物醫囑遵從性
  • 健身和營養
  • 女性健康
  • 其他

第8章虛擬實境暴露治療市場：依最終用戶分類

  • 介紹
  • 醫院和診所
  • 心理健康中心
  • 研究機構
  • 其他

第9章虛擬實境暴露治療市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 台灣
    • 其他

第10章競爭環境及分析

  • 主要企業及策略分析
  • 新興企業和市場盈利
  • 合併、收購、協議和合作
  • 供應商競爭力矩陣

第11章 公司簡介

  • VIRTUALLY BETTER, INC.
  • LIMBIX INC.
  • PSIOUS
  • OXFORD VR
  • APPLIEDVR, INC.
  • VIRTUAL REALITY MEDICAL CENTER
  • VIRTUAL REHAB
  • BRAVEMIND（DEVELOPED BY USC INSTITUTE FOR CREATIVE TECHNOLOGIES）
  • XRHEALTH（FORMERLY KNOWN AS VRHEALTH）
  • COGNIFIT
簡介目錄
Product Code: KSI061615860

The virtual reality exposure therapy market is expected to grow at a CAGR of 38.53% over the forecast period.

The virtual reality exposure therapy (VRET) market is a game-changing section of mental health therapy that uses cutting-edge virtual reality (VR) technology to treat a variety of anxiety disorders and phobias. VRET provides a secure and controlled setting in which patients may address their anxieties by gradually and repeatedly exposing themselves to anxiety-inducing stimuli. VRET simulates real-life settings by immersing patients in virtual environments, allowing therapists to guide clients through therapy sessions in a controlled and supervised way. This immersive and participatory method has been shown to be beneficial in treating illnesses such as PTSD, social anxiety, and particular phobias. As mental health professionals and patients embrace this novel and promising therapy modality, the virtual reality exposure therapy market is likely to rise significantly.

Advancements in Virtual Reality Technology Enhances the Virtual Reality Exposure Therapy Market Growth.

Virtual reality (VR) technological advancements have dramatically improved the virtual reality exposure therapy (VRET) experience, propelling innovation in mental health treatment. VR technology has advanced to provide very immersive and realistic experiences, giving patients a greater sensation of presence and involvement. More lifelike and dynamic virtual worlds are made possible by improved resolution, graphics, and motion tracking capabilities. These advances enable therapists to build customized settings that closely resemble real-life conditions, allowing for individualized exposure treatment. Furthermore, the development of user-friendly and accessible VR equipment has extended VRET's accessibility to a larger patient group, making it more accessible in therapeutic settings. As VR technology advances, it has the potential to transform the area of mental health care by delivering more effective and promising therapeutic methods.

Growing Awareness and Adoption of Non-Invasive Therapies in Virtual Reality Exposure Therapy Market.

The increased acceptance and understanding of non-invasive therapies have considerably aided the growth of the virtual reality exposure therapy (VRET) market. Non-invasive treatments have gained popularity as people seek alternative treatment alternatives owing to their potential to give excellent outcomes without the need for intrusive procedures or drugs. VRET is in line with this trend, providing a non-invasive way to treat anxiety disorders and phobias via immersive virtual experiences. The demand for VRET has risen as mental health professionals and patients become more aware of the benefits of non-invasive therapy. Because of its safety, personalised approach, and capacity to minimise harmful negative effects, the treatment has become a popular option in modern mental health care.

Personalized and Targeted Treatment Approaches Boost the Virtual Reality Exposure Therapy Market Size.

Personalised and tailored treatment techniques are propelling the virtual reality exposure therapy (VRET) market forward. VRET enables therapists to design customised virtual situations based on particular patients' fears and anxieties. VRET delivers a highly personalised therapy approach by personalising the virtual experiences, ensuring that patients confront their triggers in a controlled and supportive setting. This level of customisation allows therapists to address the individual requirements and obstacles of each patient, resulting in more effective and successful outcomes. The capacity to concentrate and focus on specific fears improves the efficacy of the therapy, making VRET a helpful tool in treating numerous anxiety disorders and phobias with more accuracy and patient satisfaction.

North America is the Market Leader in the Virtual Reality Exposure Therapy Market.

North America is the market leader in the virtual reality exposure therapy (VRET) market. Several reasons contribute to the region's leadership, including modern healthcare infrastructure, a high prevalence of mental health issues, and early use of virtual reality technology in treatment settings. Several prominent firms and startups provide VRET solutions in North America, supporting innovation and driving virtual reality exposure therapy market growth. Furthermore, the region's supportive regulatory framework and growing knowledge of the benefits of VRET for anxiety and phobia therapy have boosted its market presence. As VRET gaining traction across the world, North America continues to be at the forefront of its adoption and development.

Integration of Virtual Reality Exposure Therapy in Clinical Practice in Virtual Reality Exposure Therapy Market.

Virtual reality exposure therapy (VRET) integration in clinical practice has transformed mental health therapy. VRET is smoothly integrated by therapists as a beneficial tool to supplement standard therapeutic approaches. In a controlled context, the use of immersive virtual worlds allows for systematic desensitisation to anxiety-inducing stimuli. VRET allows therapists to give exposure treatment more swiftly while precisely monitoring patients' progress. Patients confront their concerns in a secure environment by simulating real-life circumstances, resulting in fewer avoidance behaviours and improved coping methods. Furthermore, VRET may be modified to treat a wide range of anxiety disorders and phobias, increasing its adaptability and efficacy in therapeutic settings. VRET's revolutionary influence on mental health care continues to grow as more mental health practitioners incorporate it, resulting in greater treatment results for patients.

Key Developments:

  • In May 2022, Oxford VR, a virtual reality pioneer, announced the completion of a $12.5 million Series A fundraising round, the largest investment funding for VR therapy in the UK and Europe.
  • In December 2022, BehaVR and OxfordVR, two virtual reality mental and behavioural health companies, announced their merger today, backed by a $13 million Series B round led by Optum Ventures and Oxford Science Enterprises, with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures, and Thornton Capital.

Company Products:

  • Virtual Reality Analytics Platform: CognitiveVR will most likely provide a full analytics platform that allows mental health doctors and researchers to collect and analyse data from VRET sessions. During exposure therapy, this platform enables the monitoring of patient responses, behaviours, and progress.
  • Immersive Virtual Environments: Oxford VR is anticipated to provide a library of realistic virtual settings that mirror real-life scenarios, allowing patients to confront and gradually overcome specific phobias and anxieties.
  • Virtual Reality Hardware: The business may provide a suite of virtual reality technology, like as headsets and motion-tracking controllers, to provide patients with a highly realistic and engaging VRET experience.
  • LimbixVR App: Limbix is anticipated to provide a user-friendly and engaging virtual reality software for exposure treatment. The app might offer a library of immersive and configurable scenarios that mirror real-life circumstances, allowing therapists to construct customised exposure sessions for patients.

Segmentation:

By Component

  • Hardware
  • Software

By Application

  • Anxiety Disorders
  • Post-Traumatic Stress Disorder (Ptsd)
  • Phobias And Specific Fears
  • Panic Disorder
  • Obsessive-Compulsive Disorder (Ocd)
  • Others

By Type

  • Monitoring And Health Tracking
  • Disease Management
  • Remote Consultation And Telemedicine
  • Medication Adherence
  • Fitness And Nutrition
  • Women's Health
  • Others

By End-User

  • Hospitals And Clinics
  • Mental Health Centers
  • Research Institutes
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY COMPONENT

  • 5.1. Introduction
  • 5.2. HARDWARE
  • 5.3. SOFTWARE

6. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. ANXIETY DISORDERS
  • 6.3. POST-TRAUMATIC STRESS DISORDER (PTSD)
  • 6.4. PHOBIAS AND SPECIFIC FEARS
  • 6.5. PANIC DISORDER
  • 6.6. OBSESSIVE-COMPULSIVE DISORDER (OCD)
  • 6.7. OTHERS

7. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY TYPE

  • 7.1. Introduction
  • 7.2. MONITORING AND HEALTH TRACKING
  • 7.3. DISEASE MANAGEMENT
  • 7.4. REMOTE CONSULTATION AND TELEMEDICINE
  • 7.5. MEDICATION ADHERENCE
  • 7.6. FITNESS AND NUTRITION
  • 7.7. WOMEN'S HEALTH
  • 7.8. OTHERS

8. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY END-USER

  • 8.1. Introduction
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. MENTAL HEALTH CENTERS
  • 8.4. RESEARCH INSTITUTES
  • 8.5. OTHERS

9. VIRTUAL REALITY EXPOSURE THERAPY MARKET, BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. United Kingdom
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. Japan
    • 9.6.2. China
    • 9.6.3. India
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Taiwan
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. VIRTUALLY BETTER, INC.
  • 11.2. LIMBIX INC.
  • 11.3. PSIOUS
  • 11.4. OXFORD VR
  • 11.5. APPLIEDVR, INC.
  • 11.6. VIRTUAL REALITY MEDICAL CENTER
  • 11.7. VIRTUAL REHAB
  • 11.8. BRAVEMIND (DEVELOPED BY USC INSTITUTE FOR CREATIVE TECHNOLOGIES)
  • 11.9. XRHEALTH (FORMERLY KNOWN AS VRHEALTH)
  • 11.10. COGNIFIT